Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...

Senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based ...

Avelumab maintenance with axitinib interruption was feasible in metastatic renal cell carcinoma responders, according to ...

Proactive onco-coaching did not improve quality of life but was linked to better overall survival in patients with metastatic ...

The National Cancer Audit Collaborating Centre said prostate, kidney and colon cancers were the worst affected with ...

Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of ...

Symptom scores remained stable over time, with similar QOL trends in both treatment arms.

Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, ...

Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.